University of Oklahoma: clinical-trial pipeline
University of Oklahoma is the sponsor of 431 clinical trials in ClinicalTrials.gov and the EU CTIS portal; 113 are not yet finished and 7 were first posted in the last 90 days. Source: Arcadium Data, data as of .
Trials by phase
| Phase | Trials |
|---|---|
| Not applicable | 299 |
| Phase 2 | 42 |
| Phase 1 | 27 |
| Early phase 1 | 24 |
| Phase 4 | 19 |
| Phase 3 | 10 |
| Phase 2/3 | 7 |
| Phase 1/2 | 3 |
Trials by status
| Status | Trials |
|---|---|
| Completed | 220 |
| Recruiting | 68 |
| Terminated | 47 |
| Withdrawn or not authorised | 36 |
| Not yet recruiting | 23 |
| Active, not recruiting | 22 |
| Unknown | 14 |
| Suspended or halted | 1 |
Condition areas
| Area | Trials |
|---|---|
| Oncology | 100 |
| Cardiovascular | 63 |
| Women's health and obstetrics | 42 |
| Metabolic and endocrine (diabetes, obesity) | 31 |
| Nephrology and urology | 25 |
| Infectious disease and vaccines | 24 |
| Rare and genetic diseases | 23 |
| Gastroenterology and liver | 18 |
| Psychiatry and mental health | 18 |
| Respiratory | 18 |
| Neurology | 14 |
| Immunology and rheumatology | 10 |
Countries
| Country | Trials |
|---|---|
| United States | 403 |
| Russia | 4 |
| Laos | 3 |
| Bangladesh | 1 |
| Burkina Faso | 1 |
| Canada | 1 |
| Chile | 1 |
| United Kingdom | 1 |
| India | 1 |
Latest changes
| Day | Change | Trial |
|---|---|---|
| 2026-10-09 | New trial posted | Evaluating Feasibility and Acceptability of Pain Education |
| 2026-10-06 | New trial posted | AKG and Brain Health in Aging |
| 2026-09-22 | New trial posted | Biopsy-site-marker in Breast Cancer |
| 2026-09-22 | New trial posted | Protoacoustic Imaging For 3D Mapping |
| 2026-09-18 | New trial posted | Modified FOLFIRINOX and Pentamidine in Advanced and Metastatic Pancreatic Cancer |
| 2026-09-14 | New trial posted | Self-Acceptance and Supportive Accountability for Active Living Among Adults Receiving Ch… |
| 2026-09-10 | New trial posted | Designing Effective Alcohol Health Warnings: An Experimental Study With Adults in the U.S. |
Open trials
The 25 most recently changed open trials.
| Registry id | Title | Phase | Status | Countries |
|---|---|---|---|---|
| NCT06905912 | Comparison Between Spectacles and Contact Lenses | Not applicable | Not yet recruiting | United States |
| NCT07219706 | Dietary Fiber and Time Restricted Eating | Not applicable | Active, not recruiting | United States |
| NCT07622914 | The Role of Dietary Fiber in Mitigating Sarcopenia Risk in Head and Neck Cancer | Not applicable | Recruiting | United States |
| NCT07651787 | Using Light Therapy for Mild Cognitive Impairment | Not applicable | Recruiting | United States |
| NCT04948060 | Tribally Engaged Approaches to Lung Screening (TEALS) | Not applicable | Active, not recruiting | United States |
| NCT05534568 | The Oklahoma Parent-Child Assistance Program | Not applicable | Recruiting | United States |
| NCT07217574 | Program in Oncology for Tribal Health Systems. | Not applicable | Recruiting | United States |
| NCT07591428 | Reset Challenge: Reducing High-risk Drinking for Cancer Prevention | Not applicable | Recruiting | United States |
| NCT05230732 | Neuromodulation of Inflammation and Endothelial Function | Not applicable | Recruiting | United States |
| NCT03633955 | Pilot Imaging Study of Leukemia | Phase 1 | Recruiting | United States |
| NCT07703137 | NAD Supplementation in Parkinson's Disease | Not applicable | Recruiting | United States |
| NCT07520851 | Efficacy of the Buzzy System on Pain and Fear Reduction in Elbow Fracture Pin Removal | Not applicable | Recruiting | United States |
| NCT07183319 | Circulating Tumor DNA Response In Urothelial Cancer | Phase 2 | Recruiting | United States |
| NCT06163651 | Evaluating a One-Year Version of the Parent-Child Assistance Program | Not applicable | Recruiting | United States |
| NCT05512208 | A Phase 2 Study of Avutometinib (VS-6766) Plus Defactinib | Phase 2 | Recruiting | United States |
| NCT05650697 | Topical CBD Scar Outcomes Study | Early phase 1 | Not yet recruiting | United States |
| NCT07861867 | AKG and Brain Health in Aging | Phase 2 | Not yet recruiting | |
| NCT07737795 | Evaluating the Addition of OK-1 Weekly Paclitaxel in Patients With Endometrial Cancer | Phase 2 | Not yet recruiting | United States |
| NCT06820034 | Empowering Cessation ACS South Region | Phase 2/3 | Recruiting | United States |
| NCT06960798 | Characterizing the Genomic Landscape of Cancer in Native American Populations (NAT-Geno) | Not applicable | Recruiting | United States |
| NCT06516588 | tDCS for Post-Stroke Cognitive Impairment | Phase 2 | Recruiting | United States |
| NCT05617716 | Spine Radiosurgery for Symptomatic Metastatic Neoplasms | Phase 2 | Recruiting | United States |
| NCT07224282 | The Effects of Ketone Supplements With Carbohydrates on Cycling Performance Above Lactate Threshold | Early phase 1 | Not yet recruiting | United States |
| NCT02898181 | Low Level Tragus Stimulation in Acute Decompensated Heart Failure | Not applicable | Recruiting | United States |
| NCT06668350 | Attitudes and Perceptions Attitudes and Smoking Perceptions in the Real Environment -II | Not applicable | Recruiting | United States |
All sponsors: clinical-trial pipeline by sponsor.
Track a sponsor's pipeline
The API returns the same trials by sponsor website, phase, status, condition and country with a change feed, joined to hiring and public contract awards. Try it without a key on one sponsor.
Sources: ClinicalTrials.gov (U.S. National Library of Medicine, public domain) and the EU Clinical Trials Information System public portal (European Medicines Agency), data as of 2026-10-25. A trial that one register cites in the other is shown once. Organisation-level data only: investigators, contact persons and site names are not stored, and a sponsor that could be a private person is withheld. Sponsor-to-website matches are made by name and can be wrong; check the register before relying on a record. Independent of the NLM, NIH and EMA.
Cite as: Arcadium Data, "University of Oklahoma clinical trials: 113 open, 17 in phase 3", https://arcadiumdata.io/clinical-trials/sponsor/university-of-oklahoma/, data as of 2026-10-25.